0007-4883 : Requip XL 6 mg 24hr Extended Release Tablet


NDC0007-4883
Labeler: Glaxosmithkline LLC
Product Type: Human Prescription Drug
Drug Name:  Requip XL
Dosage Form: Oral Tablet, Film Coated, Extended Release
Application #: NDA022008
Rev. Date: 


Appearance:


Markings: GS;11F
Shapes:  Oval
Colors:  White
Size (mm): 13
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

GS 11F: (0007-4883) Requip XL 6 mg 24hr Extended Release Tablet by Glaxosmithkline LLC
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0007-4883-13: 30 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (0007‑4883‑13)

Active Ingredients:

  • Ropinirole Hydrochloride

Dosage Strength:

  • 6 mg

Inactive Ingredients:

  • Carboxymethylcellulose Sodium
  • Silicon Dioxide
  • Glyceryl Dibehenate
  • Hydrogenated Castor Oil
  • Hypromelloses
  • Lactose Monohydrate
  • Magnesium Stearate
  • Maltodextrin
  • Mannitol
  • Povidones

Pharmaceutical Classes:

  • Dopamine Agonists [MoA]
  • Nonergot Dopamine Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 0007-4882 Requip XL 12 mg 24hr Extended Release Tablet by Glaxosmithkline LLC
  • 0007-4885 Requip XL 2 mg 24hr Extended Release Tablet by Glaxosmithkline LLC
  • 0007-4887 24 Hr Requip XL 4 mg Extended Release Tablet by Glaxosmithkline LLC
  • 0007-4888 24 Hr Requip XL 8 mg Extended Release Tablet by Glaxosmithkline LLC
  • 0007-4890 Requip 0.25 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4891 Requip 0.5 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4892 Requip 1 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4893 Requip 2 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4894 Requip 5 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4895 Requip 3 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4896 Requip 4 mg Oral Tablet by Glaxosmithkline LLC
  • 54868-6093 Requip XL 2 mg 24hr Extended Release Tablet by Physicians Total Care, Inc.
  • 55289-470 Requip 1 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.
  • 63629-3760 Requip 1 mg Oral Tablet by Bryant Ranch Prepack

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0007-4883 QR Code

< Prev: 0007-4882Next: 0007-4885 >

Related Discussions:

ropinirole muscle weakness
I'm having serious pain, was getting much stronger through physical therapy, began ropinirole and began to have seve... 2 replies
ropinirole 1mg question
Have gad my prescription filled 2x at same pharmacy. One is a roubd blue pill with HH on one side and 974 on other side.... 1 reply
Ropinirole 1 Mg Tab
What this pill is good for? ## Ropinirole is the active ingredient in Requip, it is used to treat Parkinson's Diseas... 1 reply
ropinirole
3 mg. purple pill, M on one side and N 30 on the other side ## Yes, this does contain 3mgs of Ropinirole, a generic for ... 1 reply
hh 975 ropinirole
Is this pill HH 975 ropinirole a time released medication? I am drifting off to sleep during the day and wondered if thi... 1 reply
Glenmark ROPINIROLE HCL 2 MG 6 TIMES A DAY
HOW CAN I GET THIS MEDICATION AT A LOWER RATE. I AM NOW IN THE DONUT HOLE AND IT WILL COST ME $155.00. MY RETIRMENT INCO... 3 replies
can i take ropinirole and aleve pm together
I only sleep an hour or so, then I'm up with just the ropinirole and was just wondering if I could take aleve pm wit... 2 replies
Side Effects Of ropinirole hydrochloride.25mg
my mom has been taking syndopa275, ropark(ropinirole .25 ,lioresal-10(baclofen) & b.crip 1.25 (bromocriptine mesylat... 2 replies
color of requip XL tablets
pink, oblong pill ## What are the marking on the tablets in question? Can you please post back and clarify? This informa... 1 reply
Requip for RLS 4 mg
Have been on requip for about 8 weeks. Started off with 2 mg and am up to 4 mg per day. The requip stops the RLS for me ... 12 replies




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA